Clinic
Community Health Centers of the Central Coast INC
Community Health Centers of the Central Coast INC was paid $8.96M by Medicaid between Mar 2018 and Dec 2024, across 36 billing codes. Its largest line is T1015, a visit at a community health center or clinic (one all-in rate) — 82% of everything it billed.
33Billing provider infoCOMMUNITY HEALTH CENTERS OF THE CENTRAL COAST INC
ARROYO GRANDE, CA 93420
ARROYO GRANDE, CA 93420
33aNPI1871010280assigned 08/25/2017
33bProvider typeClinic/Center
28Total paid$8.96M
24GClaims235,736
24DCodes billed36
24AFirst – last monthMar 2018 – Dec 2024
Compared with peers
Next to other Clinic/Center providers in California
Rank by total paid#66 of 504
Median peer was paid$102K
This provider vs. median88×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official ALLEN, BARBARA controls 15+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 20,397 | $869K | |
| 2019 | 36,990 | $1.17M | |
| 2020 | 40,088 | $1.08M | |
| 2021 | 45,960 | $1.34M | |
| 2022 | 37,504 | $1.48M | |
| 2023 | 33,754 | $1.67M | |
| 2024incomplete | 21,043 | $1.34M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| T1015 | A visit at a community health center or clinic (one all-in rate)Clinic visit/encounter, all-inclusive | 82% | 50,556 | 47,396 | $7.35M |
| 0521 | 14% | 100,396 | 39,607 | $1.24M | |
| 0301 | 1.4% | 2,241 | 2,203 | $125K | |
| 0309 | <1% | 5,081 | 4,938 | $60K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 3,651 | 2,887 | $56K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | <1% | 33,011 | 30,784 | $22K |
| 0636 | <1% | 2,320 | 2,085 | $20K | |
| 99051 | <1% | 9,654 | 9,426 | $13K | |
| 0771 | <1% | 392 | 386 | $11K | |
| 0412 | <1% | 708 | 686 | $9K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 4,551 | 3,711 | $9K |
| 0307 | <1% | 3,695 | 3,173 | $8K |
24 more codes
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 2,204 | $8K |
| 0271 | <1% | 1,784 | $6K | |
| 0306 | <1% | 491 | $6K | |
| 0761 | <1% | 242 | $5K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 2,154 | $4K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 1,263 | $966.52 |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 1,150 | $278.65 |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 289 | $217.48 |
| 71046 | Radiologic examination, chest; 2 views | <1% | 42 | $164.83 |
| 81003 | <1% | 237 | $156.37 | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 2,846 | $111.30 |
| 81000 | <1% | 2,472 | $60.22 | |
| 81025 | <1% | 184 | $6.58 | |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | <1% | 21 | $0.13 |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | 0% | 2,124 | $0.00 |
| 99000 | 0% | 79 | $0.00 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 0% | 1,116 | $0.00 |
| J1030 | Injection, methylprednisolone acetate, 40 mg | 0% | 33 | $0.00 |
| 99214 | Doctor's office visit, returning patient (more involved) | 0% | 60 | $0.00 |
| J1010 | Injection, methylprednisolone acetate, 1 mg | 0% | 12 | $0.00 |
| 69209 | 0% | 87 | $0.00 | |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 0% | 538 | $0.00 |
| 99173 | 0% | 37 | $0.00 | |
| 73630 | 0% | 15 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialALLEN, BARBARA (BUSINESS OFFICE MANAGER)
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.